CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF

Delisted

CNCR was delisted on the 27th of May, 2025.

11 hedge funds and large institutions have $5.7M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$52.8K
2 -$35.7K
3 -$17K
4
Morgan Stanley
Morgan Stanley
New York
-$2K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.73M
2
$595K
3
$540K
4
$477K
5
$274K
6
$28K
7
$17K
8
$16.1K
9
$14K
10
$2K
11
$1K
12
13